Multimodal Imaging Market by Product, Technology, Application, End User

List of Tables

[187 Pages Report] The Multimodal Imaging Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.00 billion in 2024, at a CAGR 6.18% to reach USD 4.30 billion by 2030.

Multimodal imaging encompasses developing, producing, distributing, and utilizing advanced imaging technologies that combine two or more imaging modalities within a single device or system.The rising focus on early diagnosis of chronic diseases, technological advancements, an aging global population with age-related ailments increases the use of multimodal imaging. However, multimodal imaging systems' high acquisition and maintenance costs may hinder widespread adoption, especially in emerging economies with limited healthcare budgets. Nevertheless, AI-powered algorithms are expected to help streamline data analysis from multiple modalities simultaneously improving diagnostic accuracy while reducing processing time.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.83 billion
Estimated Year [2024]	USD 3.00 billion
Forecast Year [2030]	USD 4.30 billion
CAGR (%)	6.18%

Product: Increasing demand for multimodal imaging equipments for disease diagnostics

Multimodal imaging equipment employs multiple modalities such as computed tomography (CT), optical coherence tomography (OCT), magnetic resonance imaging (MRI), ultrasound positron emission tomography (PET) to capture detailed images of various biological tissues and structures. Reagents play a crucial role in multimodal imaging by enhancing the contrast between different tissues in the body or highlighting specific molecular targets related to diseases. Some common reagents used in multimodal imaging are radioisotopes for PET/Single photon emission computed tomography (SPECT) scans, gadolinium-based contrast agents for MRI, iodinated compounds for CT scans, and fluorescent dyes for optical imaging. Software solutions in multimodal imaging enable the acquisition, processing, analysis, and visualization of data from different imaging modalities. Multimodal imaging software is essential when dealing with complex diseases requiring the integration of images from various modalities.

Application: Expanding use of multimodal imaging for oncology

In cardiology applications, multimodal imaging provides healthcare professionals with detailed information regarding cardiac tissue structure, function, and perfusion. Some prominent imaging techniques include echocardiography, nuclear cardiology, and cardiac magnetic resonance imaging (MRI). Clinical applications encompass various medical disciplines that utilize multimodal imaging to enhance diagnosis, treatment planning, and disease monitoring. Techniques such as computed tomography (CT), MRI, positron emission tomography (PET), and ultrasound are employed in diverse clinical settings, including orthopedics, gastroenterology, gynecology, and pediatrics. In neurology applications, multimodal imaging is vital in understanding brain function and diagnosing neurological disorders such as Alzheimer's or multiple sclerosis by combining structural data with functional information. Oncologic multimodal imaging has significance in early detection of cancer, monitoring treatment response, and identifying recurrence post-therapy

Technology: Significant applications of PET/CT technology owing to its high sensitivity and specificity

Positron Emission Tomography/Computed Tomography (PET/CT) is an imaging technique that combines the functional information from PET with the anatomical details of CT. It is utilized in oncology, cardiology, and neurology applications for diagnosis, staging, and assessment of treatment response. Moreover, PET/Magnetic Resonance Imaging (PET/MRI) is a hybrid technology combining the metabolic information obtained from PET with the high-resolution soft tissue contrast provided by MRI. This modality benefits pediatric oncology, brain imaging for neurodegenerative diseases, and cardiovascular imaging. Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) is a versatile hybrid imaging modality that combines functional SPECT data with anatomical CT information. It is primarily employed in orthopedic, cardiac, and oncological imaging.

End-User: Proliferating demand for multimodal imaging in diagnostic centers

Academic and research institutes use multimodal imaging technology as they need advanced tools to offer better insights into various biological processes. It enables researchers to study intricate cellular structures, molecular interactions, and disease pathology with high-resolution images. Diagnostic centers provide crucial diagnostic services, including radiology, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine (NM), optical coherence tomography (OCT), and positron emission tomography (PET) scans. The increased chronic illness and the growing geriatric population have raised the need for advanced imaging systems in hospital settings.

Regional Insights

In the United States and Canada, there has been a rising demand for advanced diagnostic tools due to an aging population and surge in prevalence of chronic diseases. Investments in research and development have led to numerous patents being filed, showcasing innovation in this sector. European Union countries have also seen growth in the multimodal imaging market with increasing collaboration between academia, clinical institutions, and industry players driving innovation. In the Middle East and Africa region, improving healthcare infrastructure has created a significant growth opportunities multimodal imaging market. Governments are investing in healthcare to address the rising incidences of non-communicable diseases such as cancer and cardiovascular disorders where advanced imaging plays a crucial role. China, Japan, India, and other Asia Pacific countries are experiencing robust expansion of their multimodal imaging markets due to factors such as rapid urbanization, expanding healthcare facilities, and increasing disposable income.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multimodal Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multimodal Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Multimodal Imaging Market, highlighting leading vendors and their innovative profiles. These include Bruker Corporation, Canon Inc., GE Healthcare, Infraredx Inc., International Business Machines Corporation, Koninklijke Philips N.V., Mediso Ltd., MR Solutions Ltd., Neusoft Medical Systems Co., Ltd., Northridge Tri-Modality Imaging, Inc., PerkinElmer, Inc., Shanghai United Imaging Healthcare Co., Ltd., Siemens AG, Spectrum Dynamics Medical, Inc., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Multimodal Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Multimodal Imaging Equipment
- Reagents
- Software

Technology
- PET/CT
- PET/MRI
- SPECT/CT

Application
- Cardiology
- Clinical Applications
- Neurology
- Oncology

End User
- Academic & Research Institutes
- Diagnostic Centers
- Hospital

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Multimodal Imaging Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multimodal Imaging Market?

3. What are the technology trends and regulatory frameworks in the Multimodal Imaging Market?

4. What is the market share of the leading vendors in the Multimodal Imaging Market?

5. Which modes and strategic moves are suitable for entering the Multimodal Imaging Market?

Product Code: MRR-036C5CF3A88B

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing application of multimodal imaging
  - 5.1.1.2. Technical advancements in multimodal diagnostic modalities
  - 5.1.1.3. Surging progress for the advancement of imaging techniques
- 5.1.2. Restraints
  - 5.1.2.1. Relatively high cost of imaging systems
  - 5.1.2.2. Dearth of trained professional and lack of adequate healthcare infrastructure
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging research and development in radiotracers
  - 5.1.3.2. Introduction of next generation multimodal imaging
- 5.1.4. Challenges
  - 5.1.4.1. Strict regulatory protocols in clinical imaging technologies
5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing demand for multimodal imaging equipments for disease diagnostics
- 5.2.2. Application: Expanding use of multimodal imaging for oncology
- 5.2.3. Technology: Significant applications of PET/CT technology owing to its high sensitivity and specificity
- 5.2.4. End-User: Proliferating demand for multimodal imaging in diagnostic centers
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Multimodal Imaging Market, by Product

6.1. Introduction
6.2. Multimodal Imaging Equipment
6.3. Reagents
6.4. Software

7. Multimodal Imaging Market, by Technology

7.1. Introduction
7.2. PET/CT
7.3. PET/MRI
7.4. SPECT/CT

8. Multimodal Imaging Market, by Application

8.1. Introduction
8.2. Cardiology
8.3. Clinical Applications
8.4. Neurology
8.5. Oncology

9. Multimodal Imaging Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Diagnostic Centers
9.4. Hospital

10. Americas Multimodal Imaging Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Multimodal Imaging Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Multimodal Imaging Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Renovaro Biosciences to Acquire Multiomic, Multimodal AI Bioinformatics Startup Gedi Cube
- 13.3.2. nference and Vanderbilt University Medical Center Sign Agreement to Advance Real-World Evidence Generation in Complex Disease Populations
- 13.3.3. Funding for Correlated Multimodal Imaging projects from COMULISglobe
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio